Syndromic Testing in the Molecular Laboratory
Outcomes That Matter

syndromic testing

How can your laboratory deliver more impactful results for the detection and treatment of a broad range of infectious diseases?

Adopt a syndromic testing approach, and benefit from increased clinical value and improved patient outcomes along with cost-effective operational efficiencies!

“We are proud that our Fast Track Diagnostics (FTD) business has played a pioneering role in the development and introduction of syndromic testing for infectious diseases. At Siemens Healthineers, we believe that every successful treatment resulting in a positive patient outcome begins with a correct and timely diagnosis. We can support that belief with our comprehensive FTD portfolio, which covers more than 140 pathogens and that is fully enabled to be compatible with most instruments already in routine operations in the world’s molecular diagnostic laboratories.”

David Stein, PhD, Head of Molecular Diagnostics & Global Strategy, Siemens Healthineers


Share this page:

1Product availability will vary country to country and is subject to varying regulatory requirements. Please contact your local representative for availability.